Welcome to Multibagg AI
Log in to access personalized features
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
47.80 | 98 Cr | 7.05 | 1.05 | 0.00 | 14.55 | 16.97 | 10.09 | ||
372.90 | 96 Cr | 14.25 | 0.80 | 3.51 | 5.69 | 7.34 | 4.65 | ||
3.60 | 95 Cr | 360.00 | 0.87 | 0.00 | 0.22 | 0.29 | 0.18 | ||
6.60 | 93 Cr | 29.64 | 3.67 | 0.00 | 12.15 | 8.13 | 7.10 | ||
47.65 | 92 Cr | 14.22 | 2.29 | 0.00 | 15.87 | 8.35 | 3.41 | ||
1.18 | 87 Cr | 11.60 | 0.40 | 0.00 | 3.54 | 5.51 | 2.59 | ||
33.99 | 84 Cr | 376.44 | 6.17 | 0.00 | 1.64 | 5.53 | 1.58 | ||
| Median: 7 Co. | — | 33.99 | 93 Cr | 14.25 | 1.05 | 0.00 | 5.69 | 7.34 | 3.41 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Lykis Limited, originally Greenline Tea & Exports Ltd, is an export-oriented company dealing with FMCG, cosmetics, and other products. Initially focused on tea cultivation and marketing, it shifted focus post-2012 following a comprehensive name change and acquisitions.
In 2012, the company acquired significant shareholdings in Lykis Pharma Ltd and Jin-X Marketing Pvt Ltd, diversifying its portfolio into pharmaceuticals and cosmetics. This strategic move led to increased turnover, showcasing adaptability in a competitive market.
Despite suffering from the downturn in tea demand during 1999-2000, Lykis displayed resilience, maintaining marginal profitability amid adverse conditions like uncontrolled inflation.
Lykis's diversification into FMCGs, including food, pharma, and cosmetics, in 2013 was a strategic response to market conditions and significantly boosted turnover and business scale.
The sale of assets in Lykis Confectioners, Lyfresh Pvt Ltd, and Lykis Soaps Pvt Ltd in 2018 marked another shift, with these divestments signaling an altered business strategy.
Commercial Services & Supplies
Trading & Distributors
92 Cr
Low Risk
14.2
21.3
0.1
2.3
61.80
29.21
Sales CAGR
Profit CAGR
ROE
ROCE
Lykis Ltd (LYKISLTD) is currently trading at 45.11 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Lykis Limited, originally Greenline Tea & Exports Ltd, is an export-oriented company dealing with FMCG, cosmetics, and other products. Initially focused on tea cultivation and marketing, it shifted focus post-2012 following a comprehensive name change and acquisitions. In 2012, the company acquired significant shareholdings in Lykis Pharma Ltd and Jin-X Marketing Pvt Ltd, diversifying its portfolio into pharmaceuticals and cosmetics. This strategic move led to increased turnover, showcasing adaptability in a competitive market. Despite suffering from the downturn in tea demand during 1999-2000, Lykis displayed resilience, maintaining marginal profitability amid adverse conditions like uncontrolled inflation. Lykis's diversification into FMCGs, including food, pharma, and cosmetics, in 2013 was a strategic response to market conditions and significantly boosted turnover and business scale. The sale of assets in Lykis Confectioners, Lyfresh Pvt Ltd, and Lykis Soaps Pvt Ltd in 2018 marked another shift, with these divestments signaling an altered business strategy.
Over the past 52 weeks, Lykis Ltd has traded between a low of ₹29.21 and a high of ₹61.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Lykis Ltd has a market capitalization of approximately 92.03. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Lykis Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.22 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 92.03 Cr, Lykis Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Lykis Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Lykis Ltd is 14.22. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
1
Neutral
6
Bullish
7
Bearish
22
Neutral
7
Bullish
17
Bearish
21
Neutral
1
Bullish
10
Board Meeting
Lykis Ltd informs that the Board meeting scheduled on July 24, 2026 to consider and approve unaudited standalone and consolidated financial results for Q1 ended June 30, 2026 has been postponed due to non-availability of directors; revised date will be notified.
Board Meeting
Lykis Ltd informs that the Board meeting scheduled for 2026-07-24 to consider and approve Q1 FY2026-27 unaudited standalone and consolidated results has been postponed due to non-availability of directors; new date to be notified.
